DE3377917D1 - Dna fragments encoding for an immunogenic peptide capable of inducing in vivo synthesis of anti-polio virus antibodies - Google Patents

Dna fragments encoding for an immunogenic peptide capable of inducing in vivo synthesis of anti-polio virus antibodies

Info

Publication number
DE3377917D1
DE3377917D1 DE8383400274T DE3377917T DE3377917D1 DE 3377917 D1 DE3377917 D1 DE 3377917D1 DE 8383400274 T DE8383400274 T DE 8383400274T DE 3377917 T DE3377917 T DE 3377917T DE 3377917 D1 DE3377917 D1 DE 3377917D1
Authority
DE
Germany
Prior art keywords
inducing
dna fragments
immunogenic peptide
fragments encoding
peptide capable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8383400274T
Other languages
German (de)
English (en)
Inventor
Marc Girard
Der Werf Sylvie Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur filed Critical Institut Pasteur
Application granted granted Critical
Publication of DE3377917D1 publication Critical patent/DE3377917D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE8383400274T 1982-02-08 1983-02-08 Dna fragments encoding for an immunogenic peptide capable of inducing in vivo synthesis of anti-polio virus antibodies Expired DE3377917D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8202013A FR2521165A1 (fr) 1982-02-08 1982-02-08 Fragments d'adn codant pour un peptide immunogene susceptible d'introduire in vivo la synthese d'anticorps anti-poliovirus

Publications (1)

Publication Number Publication Date
DE3377917D1 true DE3377917D1 (en) 1988-10-13

Family

ID=9270769

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8383400274T Expired DE3377917D1 (en) 1982-02-08 1983-02-08 Dna fragments encoding for an immunogenic peptide capable of inducing in vivo synthesis of anti-polio virus antibodies

Country Status (5)

Country Link
US (1) US4968627A (enExample)
EP (1) EP0086707B1 (enExample)
CA (1) CA1213538A (enExample)
DE (1) DE3377917D1 (enExample)
FR (1) FR2521165A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW18282A1 (en) * 1981-08-31 1983-03-23 Genentech Inc Preparation of polypeptides in vertebrate cell culture
WO1983003972A1 (en) * 1982-05-06 1983-11-24 Massachusetts Institute Of Technology Production of enterovirus neutralizing antibodies from vp1
DE3382718T2 (de) * 1982-11-30 1994-05-05 Pasteur Institut Peptide, die eine Immunogen-Lage des Poliovirus des Sabin-Stammes enthalten.
US5198536A (en) * 1982-11-30 1993-03-30 Institut Pasteur Peptides comprising an immunogenic site of poliovirus and DNAs containing nucleotide sequences coding for these peptides
ATE95567T1 (de) * 1982-11-30 1993-10-15 Pasteur Institut Peptide, die eine immunogen-lage des poliovirus des sabin-stammes enthalten.
FR2548212B1 (fr) * 1983-06-29 1990-06-08 Pasteur Institut Peptides comportant un site immunogene du poliovirus et adns contenant des sequences nucleotidiques codant pour ces peptides
WO1986001828A1 (fr) * 1984-09-18 1986-03-27 Sagami Chemical Research Center Adn cyclique a double-toron, procede de preparation, microorganisme contenant ledit adn, et procede de preparation d'une proteine contenant un site de determinant d'antigene de la proteine du capside du virus de la poliomyelite vp1 utilisant le microorganisme
FR2573436B1 (fr) * 1984-11-20 1989-02-17 Pasteur Institut Adn recombinant comportant une sequence nucleotidique codant pour un polypeptide determine sous le controle d'un promoteur d'adenovirus, vecteurs contenant cet adn recombinant, cellules eucaryotes transformees par cet adn recombinant, produits d'excretion de ces cellules transformees et leurs applications, notamment a la constitution de vaccins
US6696420B1 (en) 1984-11-20 2004-02-24 Institut Pasteur Adenoviral vector with a deletion in the E1A coding region expressing a hetorologous protein
GB8508685D0 (en) * 1985-04-03 1985-05-09 Minor P D Peptides
FR2623817B1 (fr) * 1987-11-26 1990-05-04 Pasteur Institut Sondes pour la detection d'enterovirus par hybridation moleculaire et pour la discrimination entre des poliovirus et d'autres enterovirus

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4719177A (en) * 1981-04-20 1988-01-12 Massachusetts Institute Of Technology Production of complementary DNA representing RNA viral sequences by recombinant DNA methods and uses therefor
FR2506326A1 (fr) * 1981-05-19 1982-11-26 Pasteur Institut Fragments d'adn portant des parties de l'information genetique des poliovirus, notamment du type pv1, et procede pour leur obtention
US4442205A (en) * 1981-09-22 1984-04-10 The United States Of America As Represented By The Department Of Health And Human Services Simian virus recombinant that directs the synthesis of hepatitis B surface antigen
US4751083A (en) * 1982-05-06 1988-06-14 Massachusetts Institute Of Technology Production of neutralizing antibodies by polypeptide VP1 of enteroviruses and by oligopeptide fragments of polypeptide VP1
DE3382718T2 (de) * 1982-11-30 1994-05-05 Pasteur Institut Peptide, die eine Immunogen-Lage des Poliovirus des Sabin-Stammes enthalten.

Also Published As

Publication number Publication date
EP0086707A1 (fr) 1983-08-24
US4968627A (en) 1990-11-06
FR2521165B1 (enExample) 1985-05-10
CA1213538A (en) 1986-11-04
FR2521165A1 (fr) 1983-08-12
EP0086707B1 (fr) 1988-09-07

Similar Documents

Publication Publication Date Title
DE3377989D1 (en) Coding dna fragments for polypeptides containing at least one antigenic determinant of the papillomavirus particularly of the la hpv type and corresponding polypeptides
PT86318A (en) Process for the preparation of immunogenic proteins
GB2102810B (en) Human interferon-related peptides antigens antibodies and process for preparing the same
PT85849A (en) Process for the preparation of novel lymphokine related peptides
ZA831094B (en) Dna sequences,recombinant dna molecules and processes for producing human immune interferon-like polypeptides
EP0090994A3 (en) Process for the preparation of spherical alumina
DE3363642D1 (en) Process for the preparation of protein hydrolysates
DE3377917D1 (en) Dna fragments encoding for an immunogenic peptide capable of inducing in vivo synthesis of anti-polio virus antibodies
HU892118D0 (en) Process for producing heparing binding proteins dna coding these and pharmaceutical preparatives containing these proteins
ZW11281A1 (en) Dna sequences recombinant dna molecules and processes for producing polypeptides with the specifity of foot and mouth disease viral antigens
DE3361649D1 (en) Process for synthesizing peptides or peptide derivatives
PL242096A1 (en) Process for preparing novel derivatives of cyclic peptides a-21978 c
ZA833483B (en) In vitro diagnostic methods using monoclonal antibodies against connective tissue proteins
EP0110791A3 (en) Peptides containing an immunogenic site of the poliovirus, and dna's containing nucleotide fragments encoding for these peptides
ZA861767B (en) Process for preparing hepatitis b surface antigen containing particles in novel forms which are highly immunogenic
PT85538A (en) Process for preparing homogeneous recombinant immune interferon fragments
IL73569A (en) Dna-sequences encoding modified eglins,vectors containing such dna sequences,hosts transformed by the vectors,modified eglin polypeptides produced by the transformed hosts,methods for the preparation of the dna sequences,vectors and transformed hosts,processes for the preparation of modified eglins utilizing the transformed hosts and pharmaceutical products containing the modified eglins
IL69514A0 (en) Recombinant dna molecules,process for their production,their use for production of hepatitis b surface antigen(hbsag)and pharmaceutical compositions containing this hbsag
EP0154587A3 (en) Fragments of dna which encode peptides capable of inducing in vivo the synthesis of anti-hepatitis a virus antibodies
DE3364813D1 (en) Process for the preparation of protein for hydrolysis
PL241894A1 (en) Process for preparing novel peptides
NZ209307A (en) Diagnostic product: antigenic peptide produced by recombinant dna techniques
EP0159943A3 (en) Expression vectors, dna fragments, peptides, hosts, and process for production of proteins
PL242097A1 (en) Process for preparing novel derivatives of cyclic peptides a-21978 c
EP0153961A4 (en) RECOMBINANT MATERIALS AND METHOD FOR PRODUCING HUMAN CONNECTIVE TISSUE ACTIVATING PEPTIDES III AND THEIR ANALOGS.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee